Page 2 - Randall Stanicky News Today

Operator Good morning, ladies and gentlemen, and welcome to the Fourth Quarter 2020 Endo International plc Earnings Conference Call.[Operator Instructions] I would now like to turn the conference over to your host, Ms. Laure Park, Vice President, Investor Relations and Corp Affairs. Please go ahead. Laure Park -- Senior Vice President, Investor Relations and Corporate Affairs Good morning and thank you for joining us to discuss our fourth quarter and full year 2020 financial results. Joining m...

This story is available exclusively to Insider subscribers. Become an Insider and start reading now. RBC just updated its list of the most highly recommended small-cap stocks for the first quarter. Small-company stocks have been on an enormous rally that included their best month ever in November. Some experts say they still have a long way to go to catch up to the relative prices of large caps. The smallest companies on Wall Street have had a remarkable run ...

Order Reprints Text size Pfizers Covid-19 vaccine arrived at Rady Childrens Hospital in San Diego on Tuesday. ARIANA DREHSLER/AFP/Getty Images As Americans roll up their sleeves this week for the Covid-19 vaccine developed by BioNTech, RBC Capital analyst Randall Stanicky says Pfizer’s accomplishment “is nothing short of remarkable.” In a Wednesday note, the analyst remarks that Pfizer got the vaccine to market in record time, while refusing federal money g...

The Globe and Mail Bookmark Please log in to listen to this story. Also available in French and Mandarin. Log In Create Free Account Getting audio file ... This translation has been automatically generated and has not been verified for accuracy. Full Disclaimer Inside the Market’s roundup of some of today’s key analyst actions Though he thinks its US$1.68-billion acquisition of TC Pipelines LP (TCP-N) “does not move the needle in terms of upside,” Industrial Alliance Securities ...

Dec 11, 2020 9:50pm Next up? The first doses should be on their way to providers “within hours,” as promised by Pfizer CEO Albert Bourla. (Pfizer) That was fast. Just over 24 hours after an FDA advisory panel recommended emergency use of Pfizer and BioNTech’s COVID-19 vaccine, the agency followed through, authorizing the first coronavirus pandemic shot for emergency use in the U.S. The FDA had planned to authorize the vaccine on Saturday, but moved the timeline up after pressure...